Patents Assigned to Edward E. Winger
  • REAGENTS, METHODS AND KITS FOR IDENTIFYING PREGNANT HUMAN BEINGS AT RISK FOR PLACENTAL BED DISORDER(S)
    Publication number: 20220177967
    Abstract: This disclosure provides microRNA (miRNA)-based tests and treatment protocols for identifying and/or treating pregnant human beings at risk for a placental bed disorder during pregnancy, as well as reagents and/or kits relating to the same.
    Type: Application
    Filed: March 6, 2020
    Publication date: June 9, 2022
    Applicant: EDWARD E. WINGER, M.D., PROFESSIONAL CORPORATION
    Inventors: Edward WINGER, Jane REED
  • Methods and Compositions for Assessing Patients with Preeclampsia-Related Conditions Using MicroRNA
    Publication number: 20190249254
    Abstract: The invention is directed to methods and compositions for collecting a non-placental biological samples of cells and quantifying and comparing levels of expression of microRNAs to characterize a preeclampsia-related condition. The samples may be collected before or after an intervention or may be collected over a period of time. One of the samples may be a control sample. Patients may then be treated according to their response.
    Type: Application
    Filed: February 13, 2019
    Publication date: August 15, 2019
    Applicant: Edward E. Winger, M.D., Professional Corporation
    Inventors: Edward E. Winger, Jane L. Reed
  • Methods and compositions for assessing patients with preeclampsia-related conditions using microrna
    Patent number: 10323282
    Abstract: The invention is directed to methods and compositions for collecting a non-placental biological samples of cells and quantifying and comparing levels of expression of microRNAs to characterize a preeclampsia-related condition. The samples may be collected before or after an intervention or may be collected over a period of time. One of the samples may be a control sample. Patients may then be treated according to their response.
    Type: Grant
    Filed: May 21, 2013
    Date of Patent: June 18, 2019
    Assignee: Edward E. Winger, M.D., Professional Corporation
    Inventors: Edward E. Winger, Jane L. Reed
  • Real time homogeneous nucleotide assay
    Patent number: 5853990
    Abstract: A method for performing real time, homogeneous assay of a target nucleic acid comprising annealing a labeled, ribo-oligonucleotide probe to the target DNA sequence and degrading a portion of the probe with RNase H to release labeled fragments. Sequential measurements of the released fragments permits kinetic characterization of the presence of the target sequence. Preferably, the assay is integrated into a polymerase chain reaction so that target amplification can be detected in real time.
    Type: Grant
    Filed: July 26, 1996
    Date of Patent: December 29, 1998
    Assignee: Edward E. Winger
    Inventors: Edward E. Winger, Donald J. Kessler, David E. Hargrove